Relationships Between the Expressions of CDX1 and CDX2 mRNA and Clinicopathologic Features in Colorectal Cancers
Gwang Ha Kim, Dong Hyun Lee, Hyung Wook Kim, Jong Yun Cheong, Soo Boon Seo, Jeong Heo, Dae Hwan Kang, Geun Am Song, Mong Cho, Ung Suk Yang, Do Youn Park, Mi Ae Yoo
Korean J Intern Med. 2005;20(4):317-324.   Published online 2005 Dec 31     DOI: https://doi.org/10.3904/kjim.2005.20.4.317
Citations to this article as recorded by Crossref logo
Loss of the epithelial marker CDX1 predicts poor prognosis in early-stage CRC patients
Laura Solé, Teresa Lobo-Jarne, Júlia-Jié Cabré-Romans, Antón González, Lierni Fernández, Laura Marruecos, Marta Guix, Miriam Cuatrecasas, Sandra López, Beatriz Bellosillo, Ferran Torres, Mar Iglesias, Anna Bigas, Lluís Espinosa
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(3): 119658.     CrossRef
CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer
J. Olsen, S. Eiholm, L.T. Kirkeby, M.L.M. Espersen, P. Jess, I. Gögenür, J. Olsen, J.T. Troelsen
Experimental and Molecular Pathology.2016; 100(1): 59.     CrossRef
The clinical perspectives of CDX2 expression in colorectal cancer: A qualitative systematic review
J. Olsen, M.L.M. Espersen, P. Jess, L.T. Kirkeby, J.T. Troelsen
Surgical Oncology.2014; 23(3): 167.     CrossRef
Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer
E Letellier, M Schmitz, K Baig, N Beaume, C Schwartz, S Frasquilho, L Antunes, N Marcon, P V Nazarov, L Vallar, J Even, S Haan
British Journal of Cancer.2014; 111(4): 726.     CrossRef
Relationship between TNF- Gene Promoter Polymorphisms and Outcomes of Hepatitis B Virus Infections: A Meta-Analysis
Qi Xia, LinFu Zhou, Dongcheng Liu, Zhi Chen, Feng Chen, Xia Jin
PLoS ONE.2011; 6(5): e19606.     CrossRef